GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.74
Bid: 54.78
Ask: 54.82
Change: -0.90 (-1.62%)
Spread: 0.04 (0.073%)
Open: 55.92
High: 55.92
Low: 54.64
Prev. Close: 55.64
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Supplementary Prospectus

2 Mar 2022 12:52

RNS Number : 4019D
Lloyds Banking Group PLC
02 March 2022
 

2 March 2022

 

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 2 March 2022 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of Lloyds Banking Group plc.

The Supplementary Prospectus should be read and construed in conjunction with (i) the base prospectus dated 17 June 2021, (ii) the supplementary prospectuses dated 29 July 2021 and 28 October 2021 (together, the "Base Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4019D_1-2022-3-2.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Investor Relations:

Douglas RadcliffeGroup Investor Relations Director 

Tel: +44 20 7356 1571

Email: douglas.radcliffe@lloydsbanking.com

 

Corporate Affairs:

 

Matt Smith

Head of Corporate Media

Tel: +44 20 7356 3522

E-mail: matt.smith@lloydsbanking.com

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburghEH1 1YZ

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPUUSURUKUORAR
Date   Source Headline
1st Mar 20226:01 pmRNSTransaction in Own Shares
1st Mar 20222:00 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNS2021 Form 20F Filed
28th Feb 20225:39 pmRNSTransaction in Own Shares
28th Feb 20224:02 pmRNSTotal Voting Rights
25th Feb 20226:23 pmRNSTransaction in Own Shares
25th Feb 20221:00 pmRNSBlock Listing of Shares
25th Feb 20227:05 amRNSShare Buyback Programme Commences
24th Feb 20227:00 amRNS2021 Full Year Results
24th Feb 20227:00 amRNS2021 Annual Report and Accounts
18th Feb 20222:23 pmRNSNotice of Redemption
10th Feb 20222:00 pmRNSDirector/PDMR Shareholding
31st Jan 20222:28 pmRNSTotal Voting Rights
13th Jan 20227:00 amRNSPublication of Final Terms Replacement
12th Jan 20225:54 pmRNSPublication of Final Terms
11th Jan 20222:00 pmRNSDirector/PDMR Shareholding
4th Jan 20222:00 pmRNSBlock listing Interim Review
4th Jan 20229:46 amRNSNotice of Regulatory and Capital Event Redemptions
31st Dec 202111:00 amRNSTotal Voting Rights
17th Dec 20212:00 pmRNSDirector/PDMR Shareholding
17th Dec 20212:00 pmRNSBlock Listing of Shares
13th Dec 20216:04 pmRNSBank of England Stress Test Passed
10th Dec 20213:00 pmRNSDirector/PDMR Shareholding
10th Dec 202111:28 amRNSExchange Offer Final Results
10th Dec 202111:28 amRNSTender Offer Final Results
7th Dec 20214:08 pmRNSExchange Offer Pricing Terms
30th Nov 20212:00 pmRNSTotal Voting Rights
22nd Nov 202111:02 amRNSTender Offer First Results
11th Nov 20212:00 pmRNSDirector/PDMR Shareholding
10th Nov 20213:53 pmRNSCapital Securities Update and Exchange Offer
10th Nov 20213:53 pmRNSCapital Securities Update and Tender Offer
29th Oct 20212:00 pmRNSTotal Voting Rights
28th Oct 202112:49 pmRNS2021 Q3 Interim Management Statement
28th Oct 202112:41 pmRNSPublication of Supplementary Prospectus
28th Oct 20217:00 amRNS2021 Q3 Interim Management Statement
12th Oct 20212:33 pmRNSDirector/PDMR Shareholding
30th Sep 20212:00 pmRNSTotal Voting Rights
24th Sep 20211:19 pmRNSDirector/PDMR Shareholding
23rd Sep 20219:00 amRNSDirectorate Change
22nd Sep 20212:18 pmRNSDirector/PDMR Shareholding
21st Sep 20214:10 pmRNSDirector/PDMR Shareholding
17th Sep 20214:40 pmRNSSecond Price Monitoring Extn
17th Sep 20214:36 pmRNSPrice Monitoring Extension
15th Sep 20213:42 pmRNSDirector/PDMR Shareholding
14th Sep 20212:51 pmRNSLBCM half-year news release
10th Sep 20212:00 pmRNSDirector/PDMR Shareholding
31st Aug 20212:00 pmRNSTotal Voting Rights
16th Aug 20217:00 amRNSGroup Chief Executive
10th Aug 20212:00 pmRNSDirector/PDMR Shareholding
30th Jul 20212:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.